861 related articles for article (PubMed ID: 12413882)
21. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions.
Del Maschio A; Zanetti A; Corada M; Rival Y; Ruco L; Lampugnani MG; Dejana E
J Cell Biol; 1996 Oct; 135(2):497-510. PubMed ID: 8896605
[TBL] [Abstract][Full Text] [Related]
22. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
23. ADAM15 is an adherens junction molecule whose surface expression can be driven by VE-cadherin.
Ham C; Levkau B; Raines EW; Herren B
Exp Cell Res; 2002 Oct; 279(2):239-47. PubMed ID: 12243749
[TBL] [Abstract][Full Text] [Related]
24. Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin.
Venkiteswaran K; Xiao K; Summers S; Calkins CC; Vincent PA; Pumiglia K; Kowalczyk AP
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C811-21. PubMed ID: 12176738
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation and disorganization of vascular-endothelial cadherin in interaction between breast cancer and vascular endothelial cells.
Cai J; Jiang WG; Mansel RE
Int J Mol Med; 1999 Aug; 4(2):191-5. PubMed ID: 10402488
[TBL] [Abstract][Full Text] [Related]
26. Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization.
Navarro P; Ruco L; Dejana E
J Cell Biol; 1998 Mar; 140(6):1475-84. PubMed ID: 9508779
[TBL] [Abstract][Full Text] [Related]
27. Distribution of adherens junction mediated by VE-cadherin complex in rat spleen sinus endothelial cells.
Uehara K
Cell Tissue Res; 2006 Mar; 323(3):417-24. PubMed ID: 16244888
[TBL] [Abstract][Full Text] [Related]
28. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels.
Bach TL; Barsigian C; Chalupowicz DG; Busler D; Yaen CH; Grant DS; Martinez J
Exp Cell Res; 1998 Feb; 238(2):324-34. PubMed ID: 9473340
[TBL] [Abstract][Full Text] [Related]
29. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells.
Tinsley JH; Wu MH; Ma W; Taulman AC; Yuan SY
J Biol Chem; 1999 Aug; 274(35):24930-4. PubMed ID: 10455168
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases.
Herren B; Levkau B; Raines EW; Ross R
Mol Biol Cell; 1998 Jun; 9(6):1589-601. PubMed ID: 9614196
[TBL] [Abstract][Full Text] [Related]
31. Human Schlemm's canal cells express the endothelial adherens proteins, VE-cadherin and PECAM-1.
Heimark RL; Kaochar S; Stamer WD
Curr Eye Res; 2002 Nov; 25(5):299-308. PubMed ID: 12658549
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the expression of VE-cadherin/catenin complex by gamma linolenic acid in human vascular endothelial cells, and its impact on angiogenesis.
Cai J; Jiang WG; Mansel RE
Biochem Biophys Res Commun; 1999 Apr; 258(1):113-8. PubMed ID: 10222244
[TBL] [Abstract][Full Text] [Related]
33. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin).
Lampugnani MG; Corada M; Caveda L; Breviario F; Ayalon O; Geiger B; Dejana E
J Cell Biol; 1995 Apr; 129(1):203-17. PubMed ID: 7698986
[TBL] [Abstract][Full Text] [Related]
34. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation?
Ilan N; Tucker A; Madri JA
Lab Invest; 2003 Aug; 83(8):1105-15. PubMed ID: 12920240
[TBL] [Abstract][Full Text] [Related]
36. VEGF stimulates tyrosine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction.
Cohen AW; Carbajal JM; Schaeffer RC
Am J Physiol; 1999 Nov; 277(5):H2038-49. PubMed ID: 10564161
[TBL] [Abstract][Full Text] [Related]
37. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin.
Ukropec JA; Hollinger MK; Salva SM; Woolkalis MJ
J Biol Chem; 2000 Feb; 275(8):5983-6. PubMed ID: 10681592
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
39. Role of cadherins and plakoglobin in interendothelial adhesion under resting conditions and shear stress.
Schnittler HJ; Püschel B; Drenckhahn D
Am J Physiol; 1997 Nov; 273(5):H2396-405. PubMed ID: 9374777
[TBL] [Abstract][Full Text] [Related]
40. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells.
Otero K; Martínez F; Beltrán A; González D; Herrera B; Quintero G; Delgado R; Rojas A
Biochem J; 2001 Nov; 359(Pt 3):567-74. PubMed ID: 11672430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
